SCHEMBL793474

SCHEMBL793474

Cc1ccncc1N1CCc2cc(F)c(Cl)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.41
CYP11B1 P15538 2/20 0.41
HTR2A P28223 4/20 0.38
HTR2C P28335 4/20 0.38
HTR2B P41595 2/20 0.38
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAOB P27338 1/20 0.34
CYP17A1 P05093 2/20 0.34
CYP1A2 P05177 1/20 0.34
PDE10A Q9Y233 1/20 0.34
BCL2A1 Q16548 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798146 0.85 DRD1 (0.42) CYP11B2CYP11B1HTR2AHTR2CHTR2B
SCHEMBL793623 0.83 MAPT (0.52) HTR2CMAPTALDH1A1LMNAMAPK1
SCHEMBL798654 0.79 PDGFRB (0.43) CYP11B2CYP11B1PDGFRBKDR
SCHEMBL793143 0.76 GRIN2D (0.42) CYP11B2CYP11B1PDGFRBKDRMAPT
SCHEMBL793875 0.76 TRPV3 (0.41) HTR2AHTR2CPDGFRBKDRPDE10A
SCHEMBL794272 0.76 PHGDH (0.43) HTR2AHTR2CPDGFRBKDRPDE10A
SCHEMBL807910 0.75 CYP11B2 (0.59) CYP11B2CYP11B1HTR2AHTR2CHTR2B
SCHEMBL798533 0.74 TIPARP (0.46) CYP11B2CYP11B1PDGFRBKDRMAPT
SCHEMBL798567 0.71 CYP17A1 (0.44) CYP17A1
SCHEMBL16486036 0.71 NPY5R (0.37) CYP11B2CYP11B1PDGFRBKDRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed